Detalhe da pesquisa
1.
Gene expression markers in peripheral blood and outcome in patients with platinum-resistant ovarian cancer: A study of the European GANNET53 consortium.
Int J Cancer
; 2024 Apr 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-38676430
2.
A double-blind, randomized phase II study to evaluate the safety and efficacy of acetyl-L-carnitine in the prevention of sagopilone-induced peripheral neuropathy.
Oncologist
; 18(11): 1190-1, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-24105751
3.
Atezolizumab plus Magrolimab, Niraparib, or Tocilizumab versus Atezolizumab Monotherapy in Platinum-Refractory Metastatic Urothelial Carcinoma: A Phase Ib/II Open-Label, Multicenter, Randomized Umbrella Study (MORPHEUS Urothelial Carcinoma).
Clin Cancer Res
; 29(21): 4373-4384, 2023 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37651261
4.
[Expectation about maintenance therapy among the GINECO French ovarian cancer cohort from the European NOGGO/ENGOT-ov22 Expression IV survey]. / Attentes des patientes suivies pour un cancer de l'ovaire concernant les traitements d'entretien : résultats de la cohorte française GINECO de l'enquête européenne NOGGO/ENGOT-ov22 (Expression IV).
Bull Cancer
; 105(5): 465-474, 2018 May.
Artigo
em Francês
| MEDLINE | ID: mdl-29544693